ECG necklace for self-monitoring heart rhythm

ECG necklace for self-monitoring heart rhythm

Heart2Save, Lumoava combined their expertise to develop a new generation medical device, the AiVoni {heart} Lumoava ECG necklace.

Finland-based Heart2Save and Lumoava have developed the ECG necklace, AiVoni đź’— Lumoava that delivers reliable arrhythmia analysis for self-monitoring in a stylish, unnoticeable way, no matter where you are.

New products for the identification and screening of arrhythmias are being developed at high speed all over the world. The consumer experience is vital, the products must be easy and practical to use in everyday life. Stylish design and ease of use play a significant role in how the consumer embraces the product in the long run. In wellness and sports products, the design is something that is self-evident, but when talking about medical devices, the AiVoni đź’— Lumoava ECG necklace is the starting point for a new era of self-monitoring.

“Heart2Save has strong roots in science, and our products are medical devices. They have thus gone through the same demanding process as devices used in hospitals, so the information they provide can be trusted. In order to catch an occasional arrhythmia or asymptomatic atrial fibrillation repeated measurements are required. The measurements are easily done with a device that you always have with you, like a piece of jewelry. A medical device, as a design product, also does not stigmatize the user as someone having a heart disease. These were the starting points for Heart2Save's and Lumoava's idea to make a necklace into a medical device,” says Helena Jäntti, Emergency Doctor, CEO Heart2Save.

The research behind the ECG-necklace was first showcased at a scientific congress organized by the European Society of Cardiology (ESC) in May 2020. According to the findings, the ECG-necklace produced ECG recordings with excellent quality, from where both cardiologists and AiVoni arrhythmia detection algorithms could reliably identify arrhythmia. In self-monitoring products, accurate AI-based analyses are necessary so that the consumer doesn't have to interpret the ECG him/herself. The results received widespread international attention.

“It was easy for Lumoava to start a collaboration with Heart2Save, as we share the same values and have the right combination of expertise and knowledge. We have 75 years of experience in designing jewelry and working with silver, so it has been truly inspiring to join forces in the challenging process of designing and manufacturing this innovative medical device,” says Mikko Pessi, CEO of Saurum.